-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Matinas BioPharma Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
- Matinas BioPharma Holdings, Inc. Return On Assets for the quarter ending June 30, 2024 was -92.7 %, a 84.6% decline year-over-year.
- Matinas BioPharma Holdings, Inc. annual Return On Assets for 2023 was -72.2 %, a 72.3% decline from 2022.
- Matinas BioPharma Holdings, Inc. annual Return On Assets for 2022 was -41.9 %, a 21.7% decline from 2021.
- Matinas BioPharma Holdings, Inc. annual Return On Assets for 2021 was -34.4 %, a 18.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)